Swiss drug maker Roche Holding AG blamed the strength of the franc Thursday for a 9 percent year-on-year drop in first quarter sales, but also felt the impact of regulatory concerns over its Avastin cancer medicine and an expected drop in Tamiflu orders.Full story
The outbreak of the H1N1 influenza has major political and public-health ramifications, but it's also causing agita for the business sector. Full story
ZURICH (Reuters) - Swiss drugmaker Roche Holding AG <ROG.VX> said on Thursday it controlled a total of 96.2 percent of Genentech <DNA.N> shares after completing its tender offer for the 44 percent stake it did not already own. Full story
